MabVax Therapeutics board authorizes company to explore strategic alternatives
MabVax Therapeutics announced that following authorization from the Board of Directors, it plans to engage an independent financial advisory firm to assist the Company in exploring and evaluating strategic options with the goal of maximizing shareholder value. July 24, 2017